About Open Source Pharma Foundation
Open Source Pharma Foundation is a company. Open Source Pharma Foundation offers products and services including Open Source COVID-19 Vaccine and Drug Repurposing.
-
Sectors
Healthcare
-
Phone
Locked
- Legal Name Open Source Pharma Foundation
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$280.67 K (USD)7.96as on Mar 31, 2020
-
Net Profit
$3.57 K (USD)-93.23as on Mar 31, 2020
-
EBITDA
-$215.35 K (USD)-4.31as on Mar 31, 2020
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Open Source Pharma Foundation
Open Source Pharma Foundation offers a comprehensive portfolio of products and services, including Open Source COVID-19 Vaccine and Drug Repurposing.
Research and clinical trials for vaccines are carried out using open source methodologies to address global health needs
Drug repurposing efforts are focused on exploring existing compounds for new treatments through collaborative platforms
Funding Insights of Open Source Pharma Foundation
Detailed funding history for Open Source Pharma Foundation
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Open Source Pharma Foundation
Investment portfolio details for Open Source Pharma Foundation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Open Source Pharma Foundation
Detailed financials for Open Source Pharma Foundation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Open Source Pharma Foundation Comparisons
Peer comparison for Open Source Pharma Foundation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Open Source Pharma Foundation
Detailed competitors of Open Source Pharma Foundation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Open Source Pharma Foundation
Complete news archive for Open Source Pharma Foundation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Open Source Pharma Foundation
Annual revenue of Open Source Pharma Foundation is $280.67K as on Mar 31, 2020.
The Open Source Pharma Foundation is recognized for promoting open source principles to develop affordable medicines, particularly in areas of unmet health needs. Efforts are directed towards collaborative projects like COVID-19 vaccine trials, drug repurposing, and partnerships with global institutions such as WHO and Harvard. Clinical trials for off-patent vaccines and research on innate immunity are undertaken to foster innovation. This approach is supported by events and community building, aiming to create a new paradigm in pharmaceutical development that prioritizes accessibility and shared knowledge, as evidenced by mentions in major publications like The New York Times and Newsweek.
Open Source Pharma Foundation offers Open Source COVID-19 Vaccine and Drug Repurposing.